Find a Provider

John H. Glick, MD

John H. Glick, MD Physician

Associate Dean for Resource Development, Perelman School of Medicine
President, Abramson Family Cancer Research Institute
Vice President, University of Pennsylvania Health System
Madlyn & Leonard Abramson Professor of Clinical Oncology

Dr. Glick is a Penn Medicine employed physician.

About Dr. J Glick

Recognized annually in Philadelphia Magazine's Top Docs issue from 2004 through 2015

Recognized by America's Top Doctors, 2007, 2008, 2010, 2011, 2014

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Clinical Specialties


  • Medicine
    • Medical Oncology

Programs & Services:

  • Cancer
    • Breast Cancer
    • Lymphoma

Board Certification:

  • Internal Medicine, 1973
  • Medical Oncology, 1975

Conditions & Treatments:

  • Breast Cancer
  • Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
  • Ductal Carcinoma in Situ (DCIS)
  • Hodgkin Lymphoma
  • Hodgkin's lymphoma
  • Inflammatory Breast Cancer (IBC)
  • Invasive (Infiltrating) Ductal Carcinoma (IDC)
  • Invasive (Infiltrating) Lobular Carcinoma (ILC)
  • Lymphoma
  • Male Breast Cancer
  • Non-Hodgkin Lymphoma
  • non-Hodgkin's lymphoma
  • Other types of Breast Cancer
  • Triple-Negative Breast Cancer

Practice Locations and Appointments

  • Rena Rowan Breast Center

    Abramson Cancer Center Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Columbia University
Residency: NewYork-Presbyterian/Columbia University Medical Center
Fellowship: National Cancer Institute
Fellowship: Stanford University School of Medicine


Accreditation Council for Graduate Medical Education, American Association for Cancer Research, American Association of Cancer Institutes, National American Board of Internal Medicine, American Board of Medical Specialties, American Cancer Society Philadelphia Division, American Cancer Society Scientific Advisory Committee, American Clinical and Climatological Association, National American College of Physicians, American College of Physicians, American Radium Society, American Society of Breast Disease, American Society of Clinical Oncology, American Society of Hematology, American Society of Therapeutic Radiation Oncology, Association of American Cancer Institutes, Association of Subspecialty Professors, Cancer Research Fund Of the Damon Runyon-Walter Winchall Foundation, College of Physicians of Philadelphia, Conquer Cancer Foundation, National Eastern Cooperative Oncology Group, General Motors Cancer Research Foundation, John Morgan Society, University of Pennsylvania, National Cancer Institute, National Cancer Legislation Advisory Committee, NIH Advisory Group: 1980-85 Radiosensitizer/Radioprotector Working Group, Radiotherapy Development Branch, NCI, NIH Study Section: 1980-83 Clinical Trials Review Committee, National Cancer Institute,


Dr. Glick is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

DeMichele A., Putt M., Zhang Y., Glick JH., Norman S.: Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients Cancer 97 (9): 2150-9,2003.

Yuan CM., Stein S., Glick JH., Wasik MA.: Natural killer-like T-cell lymphoma of the small intestine with a distinct immunophenotype and lack of association with gluten-sensitive enteropathy Archives of Pathology & Laboratory Medicine 127 (3): e142-6,2003.

Schulman KA., Stadtmauer EA., Reed SD., Glick HA., Goldstein LJ., Pines JM., Jackman JA., Suzuki S., Styler MJ., Crilley PA., Klumpp TR., Mangan KF., Glick JH.: Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer Bone Marrow Transplantation 31 (3): 205-10,2003.

Duggan DB., Petroni GR., Johnson JL., Glick JH., Fisher RI., Connors JM., Canellos GP., Peterson BA.: Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.[see comment] Journal of Clinical Oncology 21 (4): 607-14,2003.

Goldhirsch A., Glick JH., Gelber RD., Coates AS., Senn HJ.: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.[see comment]. [Review] [84 refs] Journal of Clinical Oncology 19 (18): 3817-27,2001.

Wiernik PH., Leong T., Oken MM., Neiman RS., Habermann TM., Bennett JM., Schuster S., Glick JH.: Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481) Leukemia & Lymphoma 40 (3-4): 357-63,2001.

Chang JH., Vines E., Bertsch H., Fraker DL., Czerniecki BJ., Rosato EF., Lawton T., Conant EF., Orel SG., Schuchter L., Fox KR., Zieber N., Glick JH., Solin LJ.: The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience Cancer 91 (7): 1231-7,2001.

Deming RL., Constine LS., Elman AJ., Hoppe RT., Mauch PM., Dosoretz DE., Pistenmaa DA., Prosnitz LR., Wolkov HB., Yahalom J., Chauvenet A., Connors JM., Glick JH., Leibel S.: Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria Radiology 215 Suppl : 1269-79,2000.

Prosnitz LR., Connors JM., Deming RL., Yahalom J., Mauch PM., Constine LS., Dosoretz DE., Elman AJ., Hoppe RT., Pistenmaa DA., Wolkov HB., Chauvenet A., Glick JH., Leibel S.: Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria Radiology 215 Suppl : 1257-68,2000.

Constine LS., Wolkov HB., Yahalom J., Mauch PM., Deming RL., Dosoretz DE., Elman AJ., Hoppe RT., Pistenmaa DA., Prosnitz LR., Chauvenet A., Connors JM., Glick JH., Leibel S.: Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria Radiology 215 Suppl : 1225-56,2000.

Academic Contact Info

Perelman Center for Advanced Medicine
3 West Pavilion, Suite 3-300S
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 662-6065
Fax: (215) 349-5325
Patient appointments: 800-789-PENN (7366)

Related Links